News
Telecoms update: NL Court of Appeal about to shed light on FRAND issues
For the first time since the CJEU decision in Huawei v ZTE, the Dutch Court of Appeal has the opportunity to provide insight into how the FRAND-ness of the business conduct of a SEP-owner is to be assessed. After a long period of silence in Dutch case law on FRAND-issues, there are promising developments ahead,
Read more ›
Rankings Chambers Global 2019: again great results for BarentsKrans
Chambers Global 2019 was published today, the guide that provides a global overview of five international jurisdictions. BarentsKrans has a number of wonderful mentions for Corporate/M&A, Intellectual Property and Dispute Resolution. Feedback from clients and peers The yearly Chambers ranking lists are based upon feedback received from clients as well as peer reviews. Chambers is
Read more ›
A filing emergency?
LEGAL POSSIBILITIES AGAINST LARGE-SCALE TRADE MARK FILERS & TRADE MARK SQUATTERS, PART 1: A mysterious trade mark filer called Michael Gleissner Trade mark squatters are a widespread IP phenomenon that every major trade mark owner shall, unfortunately, be familiar with. Recent developments in the trade mark world have led to new attention for actions by
Read more ›
Pharma update: SPC for ezetimibe + simvastatin provisionally invalid
In its judgment in interim relief proceedings of 23 October 2018 in the case Merck Sharp & Dohme Corp. / Teva Nederland B.V., Pharmachemie B.V. and Centrafarm B.V. the Court of Appeal of The Hague denied Merck Sharp & Dohme’s claim for injunctive relief regarding the sale of a generic combination product of ezetimibe +
Read more ›
Pharma update: injunction against generic combination of ezetimibe and simvastatin denied
In the interim relief decision of 11 June 2018 (ECLI:NL:RBDHA:2018:6802) in the matter Merck Sharp & Dohme Corp. / Teva Nederland B.V, Pharmachemie B.V. and Centrafarm B.V. the Provisions Judge of the District Court of The Hague rejected the claim of Merck Sharp & Dohme Corp. for an injunction against the distribution of the generic combination
Read more ›
Great results for BarentsKrans in the Legal 500
This week Legal 500 released their 2018 rankings. As in previous years, BarentsKrans is mentioned several times in this leading, international guide for the legal profession. Again we are beyond proud of these honourable mentions. High performers BarentsKrans is mentioned at nine different practice areas. Employment, Corporate/M&A, EU & Competition, Private equity, Real estate, Commercial Litigation,
Read more ›
Pharma update: tadalafil patent invalidated
The District Court of The Hague has invalidated ICOS’ patent EP 1 173 181 B3 (‘EP ‘181’) claiming a dosage range of tadalafil for the treatment of sexual dysfunction. Icos Corporation (‘Icos’), an Eli Lilly and Company subsidiary, distributes the medicinal product Cialis® containing tadalafil for the treatment of sexual dysfunction in adult men. EP
Read more ›
Chambers Europe 2018 rankings: again splendid results for BarentsKrans
Last month we published the stunning results that BarentsKrans achieved in the Chambers 2018 Global edition. Meanwhile, the Chambers Europe guide has also been published and we would, once again, like to share our Chambers feedback with you. Chambers and Partners publish their rankings annually while comparing 53 jurisdictions across Europe, from Greenland and the United Kingdom to
Read more ›
Chambers Global 2018 rankings: excellent results for BarentsKrans
Chambers Global 2018, the guide that provides a worldwide overview of international practice areas, has just been released. BarentsKrans received several honourable mentions. This year the most noticeable mention is the Corporate / M&A practice group’s first ranking within the Mid-Markets category. Like last year, the Intellectual Property team has been rewarded with a splendid
Read more ›
Marleen van den Horst receives Client Choice award
Each year, Client Choice recognises those law firm partners around the world that stand apart for the excellent client service they provide. Uniquely, these awards survey senior corporate counsel only, with this year’s winners chosen from a pool of more than 2,000 individual client assessments. On February 8 the award for Healthcare & Life Sciences
Read more ›
